ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Oklahoma » Psychiatry

Top Psychiatry Prescribers in Oklahoma

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VANESSA WERLLA M.D.

Psychiatry

3,761

$457K

226
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $132

JEFFERY CATES DO

Psychiatry

3,906

$625K

353
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$160
Average prescription price

Avg: $132

JEFFREY MCILROY M.D.

Psychiatry

3,951

$515K

295
131 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$130
Average prescription price

Avg: $132

JAMES GILBERT MD

Psychiatry

4,132

$441K

170
72 are 65+

34%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$107
Average prescription price

Avg: $132

BRADLEY MCCLURE MD

Psychiatry

4,207

$573K

282
131 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $132

JAWAUN LEWIS D.O.

Psychiatry

4,245

$576K

163
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$136
Average prescription price

Avg: $132

JACKIE NEEL DO

Psychiatry

4,264

$547K

260
110 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$128
Average prescription price

Avg: $132

JULIA IRWIN M.D.

Psychiatry

4,770

$575K

343
106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $132

EVERETT BAYNE M.D.

Psychiatry

4,796

$623K

263
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 25%

$130
Average prescription price

Avg: $132

MARIA KANE M.D.

Psychiatry

4,838

$651K

298
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$135
Average prescription price

Avg: $132

FEI-LING YEH D.O.

Psychiatry

5,118

$861K

244
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

20%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$168
Average prescription price

Avg: $132

WILLIS HOLLOWAY M.D.

Psychiatry

5,198

$583K

170
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$112
Average prescription price

Avg: $132

ROBERT HENSLEY D.O.

Psychiatry

5,629

$753K

333
118 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$134
Average prescription price

Avg: $132

REBECCA FELICIANO M.D.

Psychiatry

5,920

$694K

398
144 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$117
Average prescription price

Avg: $132

JAHANGIR GHAZNAVI M.D.

Psychiatry

6,091

$1.18M

217
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$194
Average prescription price

Avg: $132

ERIC BROADWAY M.D.

Psychiatry

6,128

$902K

321
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$147
Average prescription price

Avg: $132

FATEMA HAQUE M.D.

Psychiatry

7,165

$954K

526
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$133
Average prescription price

Avg: $132

CHARLES LESTER MD

Psychiatry

7,616

$1.07M

470
88 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$141
Average prescription price

Avg: $132

STEVAN LAHR DO

Psychiatry

8,156

$697K

297
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $132

HAISAM AL-KHOURI MD

Psychiatry

9,329

$1.64M

726
63 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$176
Average prescription price

Avg: $132

LAWREN MERIDETH M D

Psychiatry

9,338

$1.14M

430
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$122
Average prescription price

Avg: $132

DAVID MCELWAIN M.D.

Psychiatry

9,462

$1.31M

314
27 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 25%

$138
Average prescription price

Avg: $132

PETERYNE MILLER M.D.

Psychiatry

9,895

$845K

425
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $132

ADONIS AL-BOTROS MD

Psychiatry

10,501

$1.31M

685
66 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$125
Average prescription price

Avg: $132

SHANTHARAM DARBE M.D.

Psychiatry

11,864

$1.31M

623
189 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$111
Average prescription price

Avg: $132

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank